Revolution Medicines logo

Director, Stakeholder Engagement, Congress Strategy & Operations, Congresses

Revolution Medicines

Redwood City, CAHybridPosted 1 day ago$211,000 - $264,000/year
Full TimeDirector & AboveMedical AffairsBiotechnology
Original posting ↗

Summary

As part of our expanding Medical Affairs organization, we seek a dynamic and experienced Director, Stakeholder Engagement Strategy & Operations to support the strategy, planning, and execution of global medical congress activities and elevate Revolution Medicines' presence at major scientific congresses as our portfolio and organization grow. This individual will report to the Head of Scientific Stakeholder Engagement within Global Medical Excellence and will partner cross-functionally with Commercial, Clinical Development, and Research, providing leadership for global congress activities to ensure seamless integration of congress objectives with broader organizational priorities.

Job description

The Opportunity

As part of our expanding Medical Affairs organization, we seek a dynamic and experienced Director, Stakeholder Engagement Strategy & Operations to support the strategy, planning, and execution of global medical congress activities and elevate Revolution Medicines' presence at major scientific congresses as our portfolio and organization grow. This individual will report to the Head of Scientific Stakeholder Engagement within Global Medical Excellence and will partner cross-functionally with Commercial, Clinical Development, and Research, providing leadership for global congress activities to ensure seamless integration of congress objectives with broader organizational priorities.

Congress Strategy & Execution

  • Develop congress strategy for Medical Affairs with a focus on oncology therapeutic areas including pancreatic cancer, non-small cell lung cancer, and colorectal cancer.
  • Lead the strategy to elevate Revolution Medicines' presence at major global scientific congresses, building a best-in-class congress model that expands scientific visibility, stakeholder engagement, and impact.
  • Drive development of strategic objectives, overall congress presence, scientific messaging, and engagement plans.
  • Ensure high-quality, compliant execution of congress activities including medical booths, satellite events, and onsite pre-congress meetings.
  • Lead Medical Affairs planning for global congresses in the U.S., EU, and APAC regions, ensuring global consistency with regional adaptation.
  • Assess evolving needs and establish digital capabilities and processes to deliver timely, congress-specific scientific content to external stakeholders while ensuring appropriate governance and compliance across global markets.
  • Evaluate and shape congress key performance indicators (KPIs) to optimize approach, priorities, and investments.

Cross-Functional Collaboration

  • Partner with Commercial, Clinical Development, and Research to ensure consistent communication and scientific engagement while maintaining appropriate governance and firewalls.
  • Act as the central coordination point for cross-functional teams to align on congress priorities, deliverables, and messaging.
  • Collaborate with Publications/Medical Communications to ensure alignment of abstracts, posters, oral presentations, and key data dissemination to other congress activities.

Operational Leadership & Governance

  • Provide strategic direction and oversight to agency and vendor partners across congress activities, including booth development, ancillary events, internal meetings, and external stakeholder receptions, with accountability for budgets, timelines, operational excellence, and global and regional compliance.
  • Ensure compliance with global and regional regulatory requirements (FDA, EMA, PMDA, EFPIA, IFPMA).
  • Establish best practices, SOPs, and governance processes for global congress planning.
  • Capture and disseminate post-congress insights in collaboration with Medical Affairs Insights & Analytics and the broader Medical Affairs group.

Requirements

  • Advanced degree (MS, PharmD, PhD or equivalent in life sciences) preferred but not required
  • 10+ years' experience in Medical Affairs within the pharmaceutical/biotechnology industry
  • Preferably within a large, global pharmaceutical organization
  • Significant oncology experience
  • Strong background in congress strategy
  • Demonstrated experience leading congress strategy at scale within a global pharmaceutical or biotechnology organization
  • Track record of building high-impact, integrated scientific congress presence across multiple functions, programs, and geographies
  • Strong understanding of oncology therapeutic landscape, particularly pancreatic cancer, non-small cell lung cancer, and colorectal cancer
  • Deep knowledge of compliance standards governing global congresses and scientific exchange
  • Demonstrated ability to lead cross-functional collaboration in a complex, matrixed environment
  • Excellent project management, organizational, and communication skills
  • Experience managing budgets, vendors, and operational processes related to congresses
  • Preferred: Experience in early and late-phase development and product launch preparation in oncology
  • Preferred: Understanding of global medical congress operations and digital engagement tools
  • Preferred: Experience working in fast-paced, innovative, clinical-stage biotech organizations

Benefits

  • Competitive cash compensation
  • Equity awards
  • Health benefits
  • Learning and development opportunities

Company overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.